日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Triple combination immunotherapy with GVAX, anti-PD-1 monoclonal antibody, and agonist anti-OX40 monoclonal antibody is highly effective against murine intracranial glioma

GVAX、抗PD-1单克隆抗体和激动剂抗OX40单克隆抗体的三重联合免疫疗法对小鼠颅内胶质瘤有高效治疗作用

Nusrat Jahan, Hammad Talat, Andrea Alonso, Dipongkor Saha, William T Curry

Agonist OX40 immunotherapy improves survival in glioma-bearing mice and is complementary with vaccination with irradiated GM-CSF-expressing tumor cells

激动剂 OX40 免疫疗法可提高患有神经胶质瘤的小鼠的生存率,并与接种辐照的 GM-CSF 表达肿瘤细胞的疫苗相辅相成

Nusrat Jahan, Hammad Talat, William T Curry